BGMD Stock - BG Medicine, Inc.
Unlock GoAI Insights for BGMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $1.57M | $2.79M | $4.07M | $2.81M | $1.63M |
| Gross Profit | $1.06M | $1.83M | $2.68M | $1.86M | $1.01M |
| Gross Margin | 67.8% | 65.7% | 65.9% | 66.0% | 62.1% |
| Operating Income | $-4,630,000 | $-7,362,000 | $-14,374,000 | $-22,728,000 | $-17,485,000 |
| Net Income | $-5,303,000 | $-8,064,000 | $-15,849,000 | $-23,769,000 | $-17,582,000 |
| Net Margin | -338.6% | -289.3% | -389.1% | -844.4% | -1076.0% |
| EPS | $-0.55 | $-0.99 | $-2.33 | $-4.70 | $-3.99 |
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
Visit WebsiteEarnings History & Surprises
BGMDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2016 | Apr 4, 2016 | — | $-0.08 | — | — |
Q4 2015 | Nov 17, 2015 | — | $-0.27 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-0.10 | — | — |
Q3 2015 | Aug 14, 2015 | — | $-0.23 | — | — |
Q2 2015 | May 14, 2015 | — | $-0.16 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.15 | — | — |
Q4 2014 | Nov 13, 2014 | — | $-0.28 | — | — |
Q3 2014 | Aug 14, 2014 | $-0.24 | $-0.24 | 0.0% | = MET |
Q2 2014 | May 14, 2014 | — | $-0.32 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.28 | — | — |
Q4 2013 | Nov 6, 2013 | $-0.68 | $-0.52 | +23.5% | ✓ BEAT |
Q3 2013 | Aug 8, 2013 | $-0.80 | $-0.68 | +15.0% | ✓ BEAT |
Q2 2013 | May 9, 2013 | $-0.92 | $-0.84 | +8.7% | ✓ BEAT |
Q4 2012 | Dec 31, 2012 | — | $-0.57 | — | — |
Q4 2012 | Nov 13, 2012 | $-1.32 | $-1.36 | -3.0% | ✗ MISS |
Q3 2012 | Aug 9, 2012 | $-1.39 | $-1.28 | +7.9% | ✓ BEAT |
Q2 2012 | May 15, 2012 | $-1.24 | $-1.52 | -22.6% | ✗ MISS |
Q4 2011 | Dec 31, 2011 | — | $-0.96 | — | — |
Q4 2011 | Nov 3, 2011 | $-1.32 | $-1.00 | +24.2% | ✓ BEAT |
Q3 2011 | Aug 11, 2011 | $-1.19 | $-1.00 | +16.0% | ✓ BEAT |
Latest News
Frequently Asked Questions about BGMD
What is BGMD's current stock price?
What is the analyst price target for BGMD?
What sector is BG Medicine, Inc. in?
What is BGMD's market cap?
Does BGMD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BGMD for comparison